News from array biopharma A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:ARRY)

Feb 02, 2016, 12:00 ET
Array BioPharma.

Array BioPharma To Present At The Leerink Partners Annual Global Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Partners Annual...

Feb 02, 2016, 07:00 ET
Array BioPharma. (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2016

 Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the second quarter ending December 31, 2015 of its fiscal year and provided an...

Feb 01, 2016, 11:56 ET

Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with Array BioPharma

Dana-Farber Cancer Institute today announced an immuno-oncology collaboration with potential applicability in a wide range of oncology indications...

Jan 26, 2016, 14:32 ET
Array BioPharma.

Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2016 On February 2, 2016

Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the second quarter of fiscal 2016 and hold a conference call to discuss...

Jan 06, 2016, 10:00 ET
Array BioPharma.

Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare...

Dec 21, 2015, 07:00 ET
Array BioPharma.

Array Announces Closing Of Pierre Fabre Transaction

Array BioPharma Inc. (NASDAQ: ARRY) today announced the closing of its definitive agreement with Pierre Fabre following approval of the...

Dec 16, 2015, 06:30 ET
Array BioPharma.

Array BioPharma Announces Phase 3 Binimetinib Trial Meets Primary Endpoint For NRAS-Mutant Melanoma

 Array BioPharma (Nasdaq: ARRY) today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with...

Dec 01, 2015, 13:21 ET
Array BioPharma.

Array BioPharma To Present At The Oppenheimer Annual Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Oppenheimer Annual...

Nov 24, 2015, 15:59 ET
Array BioPharma.

Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Piper Jaffray Annual...

Nov 16, 2015, 07:30 ET
Array BioPharma.

Array BioPharma And Pierre Fabre Announce Development And Commercialization Collaboration For Two Novel Oncology Products, Binimetinib And Encorafenib

Array BioPharma Inc. (Nasdaq: ARRY) and Pierre Fabre today announced a collaboration to globally develop and commercialize Array's late-stage...

Nov 09, 2015, 17:23 ET
Array BioPharma

Array BioPharma To Present At The Stifel 2015 Healthcare And Jefferies 2015 Global Healthcare Conferences

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming...

Nov 04, 2015, 08:00 ET
Array BioPharma.

Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2016

 Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the first quarter of its fiscal year ending June 30, 2016 and provided an...

Oct 26, 2015, 16:11 ET
Array BioPharma.

Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2016 On November 4, 2015

Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the first quarter of fiscal 2016 and hold a conference call to discuss...

Sep 28, 2015, 07:00 ET
Array BioPharma.

Clinical Data Presented On Binimetinib And Encorafenib In Melanoma

 Clinical trial results from Array BioPharma's (Nasdaq:  ARRY) wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib,...

Sep 25, 2015, 08:00 ET
Array BioPharma

Array BioPharma To Hold Conference Call To Discuss Clinical Data Presentations In Melanoma And Colorectal Cancer On September 28, 2015

 Array BioPharma Inc. (Nasdaq:  ARRY) will hold a conference call to discuss preliminary results from two melanoma trials and a colorectal...

Sep 11, 2015, 08:00 ET
Array BioPharma

Array BioPharma Announces Clinical Data Presentations At The 2015 European Cancer Congress

 Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on encorafenib and binimetinib at the 2015 European Cancer Congress (ECC),...

Sep 10, 2015, 17:18 ET
Array BioPharma.

Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Morgan Stanley Global...

Sep 08, 2015, 08:00 ET
Patricia Henahan joins Array BioPharma as its Chief Financial Officer.

Array BioPharma Names Patricia Henahan As Chief Financial Officer

 Array BioPharma (NASDAQ: ARRY) announced today that it has appointed Patricia Henahan to the position of Chief Financial Officer. Ms. Henahan...

Sep 02, 2015, 17:54 ET
Array BioPharma.

Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities...

Aug 03, 2015, 08:00 ET
Array BioPharma.

Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015

 Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015. Ron...